HH

Harold Francis Hodson

GW Glaxo Wellcome: 5 patents #25 of 449Top 6%
AL Alizyme Therapeutics Limited: 4 patents #2 of 16Top 15%
NB Norgine Bv: 4 patents #15 of 45Top 35%
BW Burroughs Wellcome: 2 patents #101 of 312Top 35%
SL Smithkline Beecham Limited: 2 patents #570 of 1,624Top 40%
GL Glaxosmithkline: 1 patents #290 of 646Top 45%
📍 Sydenham, GB: #1 of 98 inventorsTop 2%
Overall (All Time): #210,387 of 4,157,543Top 6%
21
Patents All Time

Issued Patents All Time

Showing 1–21 of 21 patents

Patent #TitleCo-InventorsDate
8877750 2-oxy-benzoxazinone derivatives for the treatment of obesity Robert Downham, Timothy John Mitchell, Beverley Jane Carr, Christopher Robert Dunk, Richard Michael John Palmer 2014-11-04
7858617 2-oxy-benzoxazinone derivatives for the treatment of obesity Robert Downham, Timothy John Mitchell, Beverley Jane Carr, Christopher Robert Dunk, Richard Michael John Palmer 2010-12-28
7825113 2-oxy-benzoxazinone derivatives for the treatment of obesity Robert Downham, Timothy John Mitchell, Beverley Jane Carr, Christopher Robert Dunk, Richard Michael John Palmer 2010-11-02
7776853 2-amino-benzoxazinone derivatives for the treatment of obesity Robert Downham, Timothy John Mitchell, Beverley Jane Carr, Christopher Robert Dunk, Richard Michael John Palmer 2010-08-17
7407954 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity Christopher Robert Dunk, Richard Michael John Palmer, Dale Robert Mitchell, Veronique Birault, Russell G. Hunt 2008-08-05
RE39576 Enzyme inhibitors Richard Michael John Palmer, David A. Sawyer, Richard Graham Knowles, Karl Franzmann, Martin James Drysdale +4 more 2007-04-17
6916808 2-thio-4h-3, 1-benzoxazin-4-one derivatives for use as enzyme inhibitors Robert Downham, Richard Michael John Palmer, Christopher Robert Dunk 2005-07-12
6656934 2-amino-benzoxazinone derivatives for the treatment of obesity Robert Downham, Timothy John Mitchell, Beverley Jane Carr, Christopher Robert Dunk, Richard Michael John Palmer 2003-12-02
6624161 2-Oxy-benzoxazinone derivatives for the treatment of obesity Robert Downham, Timothy John Mitchell, Beverley Jane Carr, Christopher Robert Dunk, Richard Michael John Palmer 2003-09-23
6620848 Nitric oxide synthase inhibitors Richard Mansfield Beams, Martin James Drysdale, Karl Franzmann, Anthony Joseph Frend, Richard Graham Knowles +2 more 2003-09-16
6369272 Nitric oxide synthase inhibitors Richard Mansfield Beams, Martin James Drysdale, Karl Franzmann, Anthony Joseph Frend, Richard Graham Knowles +2 more 2002-04-09
5889056 Enzyme inhibitors Richard Michael John Palmer, David A. Sawyer, Richard Graham Knowles, Karl Franzmann, Martin James Drysdale +4 more 1999-03-30
5883130 Ng-monomethyl-l-arginine hydrochloride derivatives and their use in the treatment of septic shock 1999-03-16
5874472 Aminoacid derivatives as no synthase inhibitors Barry George Shearer, Karl Franzmann 1999-02-23
5863931 Amidino derivatives and their use as nitric oxide synthase inhibitors Richard Mansfield Beams, Richard Michael John Palmer 1999-01-26
5856565 Ng-monomethyl-l-argine hydrochloride derivatives and their use in the treatment of septic shock 1999-01-05
5767312 N.sup.G -monomethyl-L-arginine hydrochloride derivatives and their use in the treatment of septic shock 1998-06-16
4801593 Chemotherapeutic agents John F. Batchelor, John W. T. Selway, Jeremy Gilbert Vinter, Ramachanderan Iyer 1989-01-31
4563468 Chemotherapeutic agents John F. Batchelor, John W. T. Selway 1986-01-07
4461907 Amino-substituted flavans useful as anti-viral agents John F. Batchelor, Denis J. Bauer, John W. T. Selway, David A. Young 1984-07-24
4452991 Flavan derivatives useful for impairing RNA virus replication in a cell John F. Batchelor, Jeremy Gilbert Vinter 1984-06-05